APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Medical Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025192 pages

Choose your research edition.

Industry ResearchMedical Blood Products Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Blood Products Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Blood Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Blood Products Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Medical Blood Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medical Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Blood Products include Beijing Tiantan Biological Products, China Biologic Products Holdings, RAAS, HUALAN BIOLOGICAL ENGINEERING, China Resources Boya Bio-pharmaceutical Group, Takeda, Octapharma, LFB Group and Kedrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Blood Products Segment by Company

Beijing Tiantan Biological Products

China Biologic Products Holdings

RAAS

HUALAN BIOLOGICAL ENGINEERING

China Resources Boya Bio-pharmaceutical Group

Takeda

Octapharma

LFB Group

Kedrion

Grifols

CSL

BPL

Biotest

Medical Blood Products Segment by Type

Protein Products

Coagulation Factor Products

Other Blood Products

Whole Blood And Blood Components

Plasma Products

Medical Blood Products Segment by Application

Hospital

Clinic

Medical Blood Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Blood Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Medical Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Medical Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Medical Blood Products Industry Trends Table 2. Medical Blood Products Industry Drivers Table 3. Medical Blood Products Industry Opportunities and Challenges Table 4. Medical Blood Products Industry Restraints Table 5. Global Medical Blood Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Medical Blood Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Medical Blood Products Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Medical Blood Products Sales Market Share by Manufacturers Table 9. Global Medical Blood Products Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Medical Blood Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medical Blood Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Medical Blood Products Manufacturers, Product Type & Application Table 13. Global Medical Blood Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Blood Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Protein Products Table 17. Major Manufacturers of Coagulation Factor Products Table 18. Major Manufacturers of Other Blood Products Table 19. Major Manufacturers of Whole Blood And Blood Components Table 20. Major Manufacturers of Plasma Products Table 21. Global Medical Blood Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Medical Blood Products Sales by Type (2021-2026) & (K Units) Table 23. Global Medical Blood Products Sales by Type (2027-2032) & (K Units) Table 24. Global Medical Blood Products Sales Market Share by Type (2021-2026) Table 25. Global Medical Blood Products Sales Market Share by Type (2027-2032) Table 26. Global Medical Blood Products Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Medical Blood Products Revenue by Type (2021-2026) & (K Units) Table 28. Global Medical Blood Products Revenue by Type (2027-2032) & (K Units) Table 29. Global Medical Blood Products Revenue Market Share by Type (2021-2026) Table 30. Global Medical Blood Products Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Global Medical Blood Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Medical Blood Products Sales by Application (2021-2026) & (K Units) Table 35. Global Medical Blood Products Sales by Application (2027-2032) & (K Units) Table 36. Global Medical Blood Products Sales Market Share by Application (2021-2026) Table 37. Global Medical Blood Products Sales Market Share by Application (2027-2032) Table 38. Global Medical Blood Products Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Medical Blood Products Revenue by Application (2021-2026) & (K Units) Table 40. Global Medical Blood Products Revenue by Application (2027-2032) & (K Units) Table 41. Global Medical Blood Products Revenue Market Share by Application (2021-2026) Table 42. Global Medical Blood Products Revenue Market Share by Application (2027-2032) Table 43. Global Medical Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Medical Blood Products Sales by Region (2021-2026) & (K Units) Table 45. Global Medical Blood Products Sales Market Share by Region (2021-2026) Table 46. Global Medical Blood Products Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Medical Blood Products Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Medical Blood Products Sales by Country (2021-2026) & (K Units) Table 50. North America Medical Blood Products Sales by Country (2027-2032) & (K Units) Table 51. Europe Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Medical Blood Products Sales by Country (2021-2026) & (K Units) Table 53. Europe Medical Blood Products Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Medical Blood Products Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Medical Blood Products Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Medical Blood Products Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Medical Blood Products Sales by Country (2027-2032) & (K Units) Table 60. Global Medical Blood Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Medical Blood Products Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Medical Blood Products Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Medical Blood Products Revenue Market Share by Region (2021-2026) Table 64. Global Medical Blood Products Revenue Market Share by Region (2027-2032) Table 65. Beijing Tiantan Biological Products Company Information Table 66. Beijing Tiantan Biological Products Business Overview Table 67. Beijing Tiantan Biological Products Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Beijing Tiantan Biological Products Medical Blood Products Product Portfolio Table 69. Beijing Tiantan Biological Products Recent Development Table 70. China Biologic Products Holdings Company Information Table 71. China Biologic Products Holdings Business Overview Table 72. China Biologic Products Holdings Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. China Biologic Products Holdings Medical Blood Products Product Portfolio Table 74. China Biologic Products Holdings Recent Development Table 75. RAAS Company Information Table 76. RAAS Business Overview Table 77. RAAS Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. RAAS Medical Blood Products Product Portfolio Table 79. RAAS Recent Development Table 80. HUALAN BIOLOGICAL ENGINEERING Company Information Table 81. HUALAN BIOLOGICAL ENGINEERING Business Overview Table 82. HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Product Portfolio Table 84. HUALAN BIOLOGICAL ENGINEERING Recent Development Table 85. China Resources Boya Bio-pharmaceutical Group Company Information Table 86. China Resources Boya Bio-pharmaceutical Group Business Overview Table 87. China Resources Boya Bio-pharmaceutical Group Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. China Resources Boya Bio-pharmaceutical Group Medical Blood Products Product Portfolio Table 89. China Resources Boya Bio-pharmaceutical Group Recent Development Table 90. Takeda Company Information Table 91. Takeda Business Overview Table 92. Takeda Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Takeda Medical Blood Products Product Portfolio Table 94. Takeda Recent Development Table 95. Octapharma Company Information Table 96. Octapharma Business Overview Table 97. Octapharma Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Octapharma Medical Blood Products Product Portfolio Table 99. Octapharma Recent Development Table 100. LFB Group Company Information Table 101. LFB Group Business Overview Table 102. LFB Group Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. LFB Group Medical Blood Products Product Portfolio Table 104. LFB Group Recent Development Table 105. Kedrion Company Information Table 106. Kedrion Business Overview Table 107. Kedrion Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Kedrion Medical Blood Products Product Portfolio Table 109. Kedrion Recent Development Table 110. Grifols Company Information Table 111. Grifols Business Overview Table 112. Grifols Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Grifols Medical Blood Products Product Portfolio Table 114. Grifols Recent Development Table 115. CSL Company Information Table 116. CSL Business Overview Table 117. CSL Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. CSL Medical Blood Products Product Portfolio Table 119. CSL Recent Development Table 120. BPL Company Information Table 121. BPL Business Overview Table 122. BPL Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. BPL Medical Blood Products Product Portfolio Table 124. BPL Recent Development Table 125. Biotest Company Information Table 126. Biotest Business Overview Table 127. Biotest Medical Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Biotest Medical Blood Products Product Portfolio Table 129. Biotest Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Medical Blood Products Distributors List Table 133. Medical Blood Products Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Medical Blood Products Product Image Figure 2. Global Medical Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Blood Products Sales (2021-2032) & (K Units) Figure 5. Global Medical Blood Products Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Medical Blood Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Protein Products Image Figure 9. Coagulation Factor Products Image Figure 10. Other Blood Products Image Figure 11. Whole Blood And Blood Components Image Figure 12. Plasma Products Image Figure 13. Global Medical Blood Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Medical Blood Products Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Medical Blood Products Sales Market Share by Type (2021-2032) Figure 16. Global Medical Blood Products Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Medical Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Blood Products Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Global Medical Blood Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Medical Blood Products Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Medical Blood Products Sales Market Share by Application (2021-2032) Figure 24. Global Medical Blood Products Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Medical Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Medical Blood Products Revenue Market Share by Application (2021-2032) Figure 27. North America Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Medical Blood Products Sales Market Share by Country (2021-2032) Figure 29. U.S. Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Medical Blood Products Sales Market Share by Country (2021-2032) Figure 34. Germany Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Medical Blood Products Sales Market Share by Country (2021-2032) Figure 41. China Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Medical Blood Products Sales Market Share by Country (2021-2032) Figure 49. Brazil Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Medical Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Medical Blood Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Medical Blood Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Medical Blood Products Revenue (2021-2032) & (US$ Million) Figure 60. North America Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Medical Blood Products Revenue (2021-2032) & (US$ Million) Figure 62. Europe Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Medical Blood Products Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Medical Blood Products Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Medical Blood Products Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Medical Blood Products Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Products
  • Coagulation Factor Products
  • Other Blood Products
  • Whole Blood And Blood Components
  • Plasma Products
Applications
  • Hospital
  • Clinic
Companies covered
  • Beijing Tiantan Biological Products
  • China Biologic Products Holdings
  • RAAS
  • HUALAN BIOLOGICAL ENGINEERING
  • China Resources Boya Bio-pharmaceutical Group
  • Takeda
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Blood Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Blood Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Medical Blood Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Medical Blood Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Medical Blood Products Market Dynamics
  1. 2.1 Medical Blood Products Industry Trends
  2. 2.2 Medical Blood Products Industry Drivers
  3. 2.3 Medical Blood Products Industry Opportunities and Challenges
  4. 2.4 Medical Blood Products Industry Restraints
3 Medical Blood Products Market by Manufacturers
  1. 3.1 Global Medical Blood Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Medical Blood Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Medical Blood Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Medical Blood Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Blood Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Medical Blood Products Manufacturers, Product Type & Application
  7. 3.7 Global Medical Blood Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Blood Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Blood Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Blood Products Tier 1, Tier 2, and Tier 3
4 Medical Blood Products Market by Type
  1. 4.1 Medical Blood Products Type Introduction
  2. 4.1.1 Protein Products
  3. 4.1.2 Coagulation Factor Products
  4. 4.1.3 Other Blood Products
  5. 4.1.4 Whole Blood And Blood Components
  6. 4.1.5 Plasma Products
  7. 4.2 Global Medical Blood Products Sales by Type
  8. 4.2.1 Global Medical Blood Products Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Medical Blood Products Sales by Type (2021-2032)
  10. 4.2.3 Global Medical Blood Products Sales Market Share by Type (2021-2032)
  11. 4.3 Global Medical Blood Products Revenue by Type
  12. 4.3.1 Global Medical Blood Products Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Medical Blood Products Revenue by Type (2021-2032)
  14. 4.3.3 Global Medical Blood Products Revenue Market Share by Type (2021-2032)
5 Medical Blood Products Market by Application
  1. 5.1 Medical Blood Products Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Medical Blood Products Sales by Application
  5. 5.2.1 Global Medical Blood Products Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Blood Products Sales by Application (2021-2032)
  7. 5.2.3 Global Medical Blood Products Sales Market Share by Application (2021-2032)
  8. 5.3 Global Medical Blood Products Revenue by Application
  9. 5.3.1 Global Medical Blood Products Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Medical Blood Products Revenue by Application (2021-2032)
  11. 5.3.3 Global Medical Blood Products Revenue Market Share by Application (2021-2032)
6 Global Medical Blood Products Sales by Region
  1. 6.1 Global Medical Blood Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Blood Products Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Blood Products Sales by Region (2021-2026)
  4. 6.2.2 Global Medical Blood Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Medical Blood Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Medical Blood Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Medical Blood Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Medical Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Medical Blood Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Medical Blood Products Revenue by Region
  1. 7.1 Global Medical Blood Products Revenue by Region
  2. 7.1.1 Global Medical Blood Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Medical Blood Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Medical Blood Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Medical Blood Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Medical Blood Products Revenue (2021-2032)
  8. 7.2.2 North America Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Medical Blood Products Revenue (2021-2032)
  11. 7.3.2 Europe Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Medical Blood Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Medical Blood Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Medical Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Beijing Tiantan Biological Products
  2. 8.1.1 Beijing Tiantan Biological Products Company Information
  3. 8.1.2 Beijing Tiantan Biological Products Business Overview
  4. 8.1.3 Beijing Tiantan Biological Products Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Beijing Tiantan Biological Products Medical Blood Products Product Portfolio
  6. 8.1.5 Beijing Tiantan Biological Products Recent Developments
  7. 8.2 China Biologic Products Holdings
  8. 8.2.1 China Biologic Products Holdings Company Information
  9. 8.2.2 China Biologic Products Holdings Business Overview
  10. 8.2.3 China Biologic Products Holdings Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China Biologic Products Holdings Medical Blood Products Product Portfolio
  12. 8.2.5 China Biologic Products Holdings Recent Developments
  13. 8.3 RAAS
  14. 8.3.1 RAAS Company Information
  15. 8.3.2 RAAS Business Overview
  16. 8.3.3 RAAS Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RAAS Medical Blood Products Product Portfolio
  18. 8.3.5 RAAS Recent Developments
  19. 8.4 HUALAN BIOLOGICAL ENGINEERING
  20. 8.4.1 HUALAN BIOLOGICAL ENGINEERING Company Information
  21. 8.4.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
  22. 8.4.3 HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Product Portfolio
  24. 8.4.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
  25. 8.5 China Resources Boya Bio-pharmaceutical Group
  26. 8.5.1 China Resources Boya Bio-pharmaceutical Group Company Information
  27. 8.5.2 China Resources Boya Bio-pharmaceutical Group Business Overview
  28. 8.5.3 China Resources Boya Bio-pharmaceutical Group Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 China Resources Boya Bio-pharmaceutical Group Medical Blood Products Product Portfolio
  30. 8.5.5 China Resources Boya Bio-pharmaceutical Group Recent Developments
  31. 8.6 Takeda
  32. 8.6.1 Takeda Company Information
  33. 8.6.2 Takeda Business Overview
  34. 8.6.3 Takeda Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Takeda Medical Blood Products Product Portfolio
  36. 8.6.5 Takeda Recent Developments
  37. 8.7 Octapharma
  38. 8.7.1 Octapharma Company Information
  39. 8.7.2 Octapharma Business Overview
  40. 8.7.3 Octapharma Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Octapharma Medical Blood Products Product Portfolio
  42. 8.7.5 Octapharma Recent Developments
  43. 8.8 LFB Group
  44. 8.8.1 LFB Group Company Information
  45. 8.8.2 LFB Group Business Overview
  46. 8.8.3 LFB Group Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LFB Group Medical Blood Products Product Portfolio
  48. 8.8.5 LFB Group Recent Developments
  49. 8.9 Kedrion
  50. 8.9.1 Kedrion Company Information
  51. 8.9.2 Kedrion Business Overview
  52. 8.9.3 Kedrion Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kedrion Medical Blood Products Product Portfolio
  54. 8.9.5 Kedrion Recent Developments
  55. 8.10 Grifols
  56. 8.10.1 Grifols Company Information
  57. 8.10.2 Grifols Business Overview
  58. 8.10.3 Grifols Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Grifols Medical Blood Products Product Portfolio
  60. 8.10.5 Grifols Recent Developments
  61. 8.11 CSL
  62. 8.11.1 CSL Company Information
  63. 8.11.2 CSL Business Overview
  64. 8.11.3 CSL Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CSL Medical Blood Products Product Portfolio
  66. 8.11.5 CSL Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BPL Medical Blood Products Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Biotest
  74. 8.13.1 Biotest Company Information
  75. 8.13.2 Biotest Business Overview
  76. 8.13.3 Biotest Medical Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biotest Medical Blood Products Product Portfolio
  78. 8.13.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Blood Products Value Chain Analysis
  2. 9.1.1 Medical Blood Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Blood Products Production Mode & Process
  6. 9.2 Medical Blood Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Blood Products Distributors
  9. 9.2.3 Medical Blood Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst